Literature DB >> 7229370

H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.

S Ostrand-Rosenberg, V L Cohan.   

Abstract

The murine 402AX teratocarcinoma is an H-2 negative, nullipotent stem cell tumor of testicular origin. Previous studies have demonstrated that host strain resistance and susceptibility to this tumor are under the control of 2 genes, one of which is closely linked to the mouse major histocompatibility complex. Earlier studies determined the lack of antigenic modulation and the absence of H-2 antigens on 402AX cells passaged in vitro or in genetically susceptible hosts. The present studies demonstrate that when passaged in genetically resistant host mice [C57BL/10, B10.SM, and B10.129(6M)], the H-2 negative 402AX cells modulate to become positive for H-2b antigens, as detected by indirect immunofluorescence, microcytotoxicity, and quantitative absorption. Two to 4 days of in vivo growth in resistant hosts is necessary for H-2b antigens to be expressed. H-2 positive tumor cells removed from resistant hosts and placed in culture become H-2 antigen negative within 1 to 4 hr in vitro. H-2 antigen turn-on on the teratocarcinoma cells is specific for the H-2 haplotype of the tumor cell origin (129, H-2b); alien H-2 antigens are not expressed. The observation that only teratocarcinoma cells growing in genetically resistant hosts turn-on for H-2 antigens suggests that major histocompatibility antigens on target cells are required for an efficient host cell-mediated immune response against tumor cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Transfected H-2Kb gene as a cause of embryonal carcinoma cell rejection in vivo.

Authors:  B Mosinger; J Forejt
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.

Authors:  L J Maher; W F Dove
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Allogeneic H-2 antigen expression is insufficient for tumor rejection.

Authors:  G A Cole; G A Cole; V K Clements; E P Garcia; S Ostrand-Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Teratocarcinoma transplantation antigens are encoded in the H-2 region.

Authors:  L L Johnson; L J Clipson; W F Dove; J Feilbach; L J Maher; A Shedlovsky
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.

Authors:  S Ostrand-Rosenberg; A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  H-2 class I antigen expression on mouse teratocarcinoma cell lines.

Authors:  P Démant; M Oudshoorn-Snoek
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Differential Hm antigen expression on EC cells and early differentiated derivatives.

Authors:  M C Simmler; P R Avner
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

8.  Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

Authors:  P Nanni; L Landuzzi; G Nicoletti; C De Giovanni; M Giovarelli; E Lalli; A Facchini; P L Lollini
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.